top of page
PUBLICATIONS

  1. Sajiir H,….Moniruzzaman M, et al. 2024. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis. Nature Communications (IF:14.7), 15(1): 4528, Cites: 1

  2. Steinmetz JD,….Moniruzzaman M, et al. 2024. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology (IF:48.0; Q1), 23 (4), 344-381.

  3. Moniruzzaman M, et al. 2024. Cannabidiol - Help and hype in targeting mucosal diseases. Journal of Controlled Release (IF:10.50), 365: 530-543, Cites: 1

  4. Gurgenci T,….Moniruzzaman M, et al. 2023. Exploring potential anti-inflammatory effects of medicinal cannabis. Supportive Care in Cancer (IF: 3.10; Q2), 31(12): 629, Cites: 1

  5. Moniruzzaman M, et al. 2023. Interleukin-22 suppresses MHC II in mucosal epithelial cells. Journal of Experimental Medicine (IF: 12.6), 220(11): e20230106, Cites: 1

  6. Sheng YH,….Moniruzzaman M, et al. 2023. Muc13 cell surface mucin limits salmonella typhimurium infection by protecting the mucosal epithelial barrier. Cellular and Molecular gastroenterology and Hepatology (IF: 7.20; Q1), 16(6): 985-1009.

  7. Cao Y,….Moniruzzaman M, et al. 2023. Virus-like silica nanoparticles enhance macromolecule permeation in vivo. Biomaterials Science, (IF: 6.6; Q1), 11: 4508, Cites: 1

  8. Black RJ,….Moniruzzaman M, et al. 2023. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology (IF: 25.4; Q1), 5(10): e594-e610, Cites: 2

  9. Moniruzzaman M, et al. 2023. IL-20 activates ERK1/2 and suppresses splicing of x-box protein-1 in intestinal epithelial cells but does not improve pathology in acute or chronic models of colitis. International Journal of Molecular Sciences (IF: 4.90), 24(1): 174, Cites 1

  10. Janjua TI,….Moniruzzaman M, et al. 2023. Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma. Journal of Controlled Release (IF:10.50), 357: 161-174, Cites: 2

  11. Ong KL,….Moniruzzaman M, et al. 2023. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet (IF: 168.9; Q1), 402: 203–34, Cites: 4

  12. Wu D,….Moniruzzaman M, et al. 2023. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. eClinicalMedicine, (IF: 15.10; Q1), 64: 102193.

  13. Momtazmanesh S,….Moniruzzaman M, et al. 2023. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. eClinicalMedicine, (IF: 15.10; Q1), 59: 101936, Cites: 2

  14. Shin YH,….Moniruzzaman M, et al. 2023. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy (IF: 12.40; Q1), 78(8): 2232-54

  15. Hmwe K,….Moniruzzaman M, et al. 2022. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases (IF: 56.30; Q1), 22(11):1626-1647, Cites 38.

  16. Nichols E,.…Moniruzzaman M, et al. 2022. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health (IF: 50.00; Q1), 7(2):e105-125, Cites: 900

  17. Moniruzzaman M, Elshaer D, et al. 2021. Facile synthesis of dendrimer like mesoporous silica nanoparticles to enhance targeted delivery of interleukin-22. Biomaterials Science, (IF: 6.6; Q1), 9(22):7402-7411, Cites: 4 (joint first author)

  18. Parekh K,…Moniruzzaman M, et al. 2021. Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitis. International Journal of Pharmaceutics, (IF: 5.80; Q1), 608:121079, Cites: 10

  19. Wang R, Moniruzzaman M, et al. 2021. Gut microbiota shape the inflammatory response in mice with an epithelial defect. Gut Microbes (IF: 12.20; Q1), 21(1): e1887720. Cites: 15

  20. Pujara N,…..Moniruzzaman M, et al. 2021. pH-responsive colloidal carriers assembled from β-lactoglobulin and epsilon poly-l-lysine for oral drug delivery. Journal of Colloid & Interface Science (IF: 9.90; Q1), 589:45-55, Cites: 27

  21. Pujara N, Wong KY, Qu Z, Wang R, Moniruzzaman M, et al. 2021. Oral delivery of β-lactoglobulin-nanosphere-encapsulated resveratrol alleviates inflammation in Winnie mice with spontaneous ulcerative colitis. Molecular Pharmaceutics (IF:4.90; Q1), 18(2):627−640, Cites:35

  22. Qu Z, Wong KY, Moniruzzaman M, et al. 2021. One-pot synthesis of pH-responsive Eudragit-mesoporous silica nanocomposites enable colonic delivery of glucocorticoids for the treatment of inflammatory bowel disease. Advanced Therapeutics (IF: 3.70), 2000165, Cites: 25

  23. Ferdous A, …. Moniruzzaman M*. 2020. The leaves of Bougainvillea spectabilis suppressed inflammation and nociception in vivo through the modulation of glutamatergic, cGMP, and ATP-sensitive K+ channel pathways. Journal of Ethnopharmacology (The official journal of the International Society for Ethnopharmacology; IF: 4.80), 161: 113148. Cites: 15

  24. Moniruzzaman M, et al. 2019. Interleukin (IL)-22 from IL-20 subfamily of cytokines induces colonic epithelial cell proliferation predominantly through ERK1/2 pathway. International Journal of Molecular Sciences (IF: 4.90), 20(14): 3468. Cites: 27

  25. Wang R, Moniruzzaman M, et al. 2018. Immune regulation of the unfolded protein response at the mucosal barrier in viral infection. Clinical & Translational Immunology (The official journal of the Australasian Society for Immunology; IF: 4.60), 7(4): e1014. Cites: 15

  26. Moniruzzaman M*, et al. 2018. HO-1 dependent antioxidant effects of ethyl acetate fraction from Physalis alkekengi fruit ameliorates scopolamine-induced cognitive impairments. Cell Stress & Chaperones (IF: 3.30), 23(4): 763-772. Cites: 15

  27. Moniruzzaman M* et al. 2018. The leaves of Crataeva nurvala Buch-Ham. modulate locomotor and anxiety behaviors possibly through GABAergic system. BMC Complementary Medicine and Therapies (IF: 3.90), 18:283. Cites: 16

  28. Moniruzzaman M, et al. 2016. The ethyl-acetate fraction from Physalis alkekengi fruit inhibits LPS-induced pro-inflammatory mediators in BV2 cells and inflammatory pain in mice. Journal of Ethnopharmacology (IF: 4.80), 181: 26–36. Cites: 37

  29. Bose S, Kim S, Oh Y, Moniruzzaman M, et al. 2016. Effect of CCL2 on BV2 microglial cell migration: Involvement of probable signaling pathways. Cytokine (The official journal of the International Cytokine and Interferon Society; IF: 3.70), 81: 39–49. Cites: 23

  30. Ani NS, Chakraborty S, Moniruzzaman M*. 2016. The methanolic extract from Murraya koenigii L. inhibits glutamate-induced pain and involves ATP-sensitive K+ channel as antinociceptive mechanism. Advances in Pharmacological and Pharmaceutical Sciences (IF: 2.1). Article ID 3790860, 2016: 1-6. Cites: 5

  31. Moniruzzaman M* et al. 2016. Evaluation of antinociceptive activity of methanolic extract of leaves of Stephania japonica Linn. Journal of Ethnopharmacology (IF: 4.80), 186: 205-208. Cites: 14

  32. Moniruzzaman M*, et al. 2016. Sedative and anxiolytic-like actions of ethanol extract of leaves of Glinus oppositifolius (Linn.) Aug. DC. Evidence-Based Complementary and Alternative Medicine (IF: 2.65), Article ID 8541017, 2016: 1-8. Cites: 12

  33. Moniruzzaman M, et al. 2015. Antioxidant and anti-inflammatory effect of N-((3, 4-dihydro-2H-benzo[h]chromen-2-yl)methyl)-4-methoxyaniline in LPS-induced BV2 microglial cells. Biological & Pharmaceutical Bulletin (IF: 1.70), 38(12): 1831-1835. Cites: 11

  34. Moniruzzaman M, et al. 2015. Evaluation of antinociceptive activity of ethanol extract of leaves of Adenanthera pavonina. Evidence-Based Complementary and Alternative Medicine (IF: 2.65), Article ID 412497, 2015: 1-8. Cites: 18

  35. Moniruzzaman M*, et al. 2015. Evaluation of antinociceptive activity of ethanol extract of bark of Polyalthia longifolia. Journal of Ethnopharmacology (IF: 4.80), 172: 364-367. Cites:15

  36. Moniruzzaman M*, et al. 2015. Evaluation of sedative and hypnotic activity of ethanolic extract of Scoparia dulcis Linn. Evidence-Based Complementary and Alternative Medicine (IF: 2.65), Article ID 873954, 2015: 1-6. Cites: 57

  37. Moniruzzaman M*, et al. 2015. Evaluation of antinociceptive activity of ethanol extract of Hedyotis corymbosa Linn. whole plant in mice. Journal of Ethnopharmacology (IF: 4.80), 161: 82-85. Cites: 19

  38. Moniruzzaman M, Imam MZ*. 2014. Evaluation of antinociceptive effect of methanolic extract of leaves of Crataeva nurvala Buch.-Ham. BMC Complementary Medicine and Therapies (IF: 3.90), 14: 354. Cites: 36

  39. Imam MZ*, Moniruzzaman M. 2014. Antinociceptive effect of ethanol extract of leaves of Lannea coromandelica. Journal of Ethnopharmacology (IF: 4.80), 154: 109-115. Cites: 25

bottom of page